Analgesics (Pharmacies) - Benelux

Revenue in the Analgesics market is projected to reach US$304.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.08%, resulting in a market volume of US$371.70m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$10.13 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Benelux is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Benelux have a growing preference for over-the-counter analgesics purchased from pharmacies. This preference is driven by the convenience of accessing these products in pharmacies, where trained pharmacists can provide advice and recommendations. Additionally, customers in the region value the wide range of analgesic options available in pharmacies, allowing them to choose products that suit their specific needs.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Benelux is the increasing demand for natural and herbal analgesics. Customers are becoming more conscious of the potential side effects of traditional analgesics and are seeking alternative options. This trend is reflected in the growing availability of natural analgesic products in pharmacies across the region. Another trend in the market is the rising popularity of online pharmacy platforms. Customers in Benelux are increasingly turning to online platforms to purchase analgesics due to the convenience and competitive pricing offered. This trend is driving the growth of e-commerce in the Analgesics (Pharmacies) market in Benelux.

Local special circumstances: One of the special circumstances in the Analgesics (Pharmacies) market in Benelux is the high level of competition among pharmacies. The region has a dense network of pharmacies, leading to intense competition for customers. This competition has resulted in pharmacies offering a wide range of analgesic products and value-added services to attract and retain customers.

Underlying macroeconomic factors: The stable economic growth in Benelux is a key underlying macroeconomic factor driving the development of the Analgesics (Pharmacies) market. As the economy continues to grow, consumers have more disposable income to spend on healthcare products, including analgesics. This increased purchasing power is contributing to the growth of the market. Furthermore, the aging population in Benelux is also influencing the market. As the population ages, the demand for analgesics is expected to increase, as older individuals are more likely to experience chronic pain and require pain relief medication. This demographic factor is driving the growth of the Analgesics (Pharmacies) market in Benelux. In conclusion, the Analgesics (Pharmacies) market in Benelux is developing due to customer preferences for pharmacy-purchased analgesics, trends such as the demand for natural and online options, local special circumstances of intense competition among pharmacies, and underlying macroeconomic factors of stable economic growth and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.